Estrella Immunopharma (ESLA) Accumulated Expenses (2023 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Accumulated Expenses of $4031.0 for Q1 2026, down 96.58% year-over-year from $117844.0 in Q1 2025, and down 92.99% quarter-over-quarter from $57501.0 in Q4 2025.
Estrella Immunopharma (ESLA) Accumulated Expenses (2023 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Accumulated Expenses for 4 consecutive years, with $4031.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 96.58% year-over-year to $4031.0; the TTM figure through Mar 2026 stood at $4031.0 (down 96.58% YoY), while the FY2025 annual figure was $57501.0, up 307.81% from the prior year.
- Accumulated Expenses fell to $4031.0 in Q1 2026 per ESLA's latest filing, from $57501.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $398781.0 in Q2 2023 and bottomed at $2167.0 in Q3 2024.
- Historically, Accumulated Expenses has averaged $106870.8 across 4 years, with a median of $84134.0 in 2025.
- Annual changes were most pronounced in 2025 — Accumulated Expenses jumped 307.81% — and 2026, when it slumped 96.58%.
- Estrella Immunopharma's Accumulated Expenses stood at $270579.0 in 2023, then tumbled by 94.79% to $14100.0 in 2024, then surged by 307.81% to $57501.0 in 2025, then plunged by 92.99% to $4031.0 in 2026.
- Business Quant data shows ESLA's Accumulated Expenses at $4031.0 in Q1 2026, $57501.0 in Q4 2025, and $3916.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 255,559.00 |
| Mar 31, 2026 | 4,031.00 |
| Dec 31, 2025 | 57,501.00 |
| Sep 30, 2025 | 3,916.00 |
| Jun 30, 2025 | 110,767.00 |
| Mar 31, 2025 | 117,844.00 |
| Dec 31, 2024 | 14,100.00 |
| Sep 30, 2024 | 2,167.00 |
| Jun 30, 2024 | 131,823.00 |
| Mar 31, 2024 | 166,941.00 |
| Dec 31, 2023 | 270,579.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 398,781.00 |